VF
KALA icon

Virtu Financial’s KALA BIO KALA Stock Holding History

Virtu Financial’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,044
Closed -$26K – 1931
2026
Q1 		$26K Buy
3,044
+1,334
+78% +$28.2K ﹤0.01% 1365
2025
Q4 		$48K Buy
+1,710
New +$76.6K ﹤0.01% 1309
2024
Q3 		– Sell
-622
Closed -$221K – 1627
2024
Q2 		$221K Buy
+622
New +$206K 0.02% 671
2022
Q4 		– Sell
-26
Closed -$14K – 1894
2022
Q3 		$14K Sell
26
-4
-13% -$3.14K ﹤0.01% 1470
2022
Q2 		$22K Sell
30
-26
-46% -$40.8K ﹤0.01% 1311
2022
Q1 		$194K Buy
56
+5
+10% +$13.1K 0.01% 790
2021
Q4 		$153K Buy
+51
New +$237K 0.02% 943
2020
Q3 		– Sell
-5
Closed -$135K – 1294
2020
Q2 		$135K Buy
+5
New +$142K 0.02% 813
2019
Q4 		$87K Buy
+9
New +$86.9K 0.01% 1110
2018
Q4 		– Sell
-8
Closed -$200K – 1778
2018
Q3 		$200K Buy
+8
New +$244K 0.01% 1076

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Virtu Financial's KALA Position: Q2 2026 in Review

Virtu Financial sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 3,044 shares — an estimated $26K sold.

Virtu Financial first reported a position in KALA in Q3 2018 and held it in 10 quarters. The position peaked at $221K in Q2 2024. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Virtu Financial reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 3,044 KALA BIO shares in Q2 2026, an estimated $26K.
  • Virtu Financial first reported a position in KALA BIO in Q3 2018 and held it in 10 quarters.
  • Virtu Financial's KALA BIO position peaked at $221K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.